10x fund lp - owned by 10x fund lp investment history in Pro pharmaceuticals inc

Filed on 2011-04-13 by 10x Capital Management, Llc SEC CIK 1457247 Form 5

Accession 0001453356-11-000002.txt Sec File: edgar/data/1457247/0001453356-11-000002-index.htm

2010-12-31 10x Fund Lp (CIK 1453356) through Owned By 10x Fund Lp

Invested in Pro Pharmaceuticals Inc bought 380475 shares at $0.9 remaining shares owned 2101748

Common Stock Pro Pharmaceuticals Inc Prwp Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 received as a dividend on class b convertible preferred stock owned by 10x fund, lp.
f2 10x fund, l.p. has direct beneficial ownership of all the securities owned by 10x fund, l.p. 10x capital management, llc, a florida limited liability company, is the general partner of 10x fund, l.p., a delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10x fund, l.p., such portion being equal to 10x capital management, llc's (a) 20% interest in the profits of 10x fund, l.p., (b) interest in any securities which are used to pay a 2% annual management fee to 10x capital management, llc, and (c) interest in one-half of the class b warrants acquired by 10x fund, l.p. in all closings other than the initial closing held on february 12, 2009, less one class b warrant which 10x capital management, llc has committed to reallocate to investors in all prior closings until each such investor has one (1) additional class b warrant for each dollar invested.
f3 10x capital management, llc disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.


Filed on 2011-04-13 by 10x Capital Management, Llc SEC CIK 1457247 Form 5

Accession 0001453356-11-000002.txt Sec File: edgar/data/1457247/0001453356-11-000002-index.htm

2010-09-30 10x Fund Lp (CIK 1453356) through Owned By 10x Fund Lp

Invested in Pro Pharmaceuticals Inc bought 380475 shares at $0.79 remaining shares owned 1721273

Common Stock Pro Pharmaceuticals Inc Prwp Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 received as a dividend on class b convertible preferred stock owned by 10x fund, lp.
f2 10x fund, l.p. has direct beneficial ownership of all the securities owned by 10x fund, l.p. 10x capital management, llc, a florida limited liability company, is the general partner of 10x fund, l.p., a delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10x fund, l.p., such portion being equal to 10x capital management, llc's (a) 20% interest in the profits of 10x fund, l.p., (b) interest in any securities which are used to pay a 2% annual management fee to 10x capital management, llc, and (c) interest in one-half of the class b warrants acquired by 10x fund, l.p. in all closings other than the initial closing held on february 12, 2009, less one class b warrant which 10x capital management, llc has committed to reallocate to investors in all prior closings until each such investor has one (1) additional class b warrant for each dollar invested.
f3 10x capital management, llc disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.


Filed on 2011-04-13 by 10x Capital Management, Llc SEC CIK 1457247 Form 5

Accession 0001453356-11-000002.txt Sec File: edgar/data/1457247/0001453356-11-000002-index.htm

2010-06-30 10x Fund Lp (CIK 1453356) through Owned By 10x Fund Lp

Invested in Pro Pharmaceuticals Inc bought 358015 shares at $0.71 remaining shares owned 1340798

Common Stock Pro Pharmaceuticals Inc Prwp Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 received as a dividend on class b convertible preferred stock owned by 10x fund, lp.
f2 10x fund, l.p. has direct beneficial ownership of all the securities owned by 10x fund, l.p. 10x capital management, llc, a florida limited liability company, is the general partner of 10x fund, l.p., a delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10x fund, l.p., such portion being equal to 10x capital management, llc's (a) 20% interest in the profits of 10x fund, l.p., (b) interest in any securities which are used to pay a 2% annual management fee to 10x capital management, llc, and (c) interest in one-half of the class b warrants acquired by 10x fund, l.p. in all closings other than the initial closing held on february 12, 2009, less one class b warrant which 10x capital management, llc has committed to reallocate to investors in all prior closings until each such investor has one (1) additional class b warrant for each dollar invested.
f3 10x capital management, llc disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.


Filed on 2011-04-13 by 10x Capital Management, Llc SEC CIK 1457247 Form 5

Accession 0001453356-11-000002.txt Sec File: edgar/data/1457247/0001453356-11-000002-index.htm

2010-03-31 10x Fund Lp (CIK 1453356) through Owned By 10x Fund Lp

Invested in Pro Pharmaceuticals Inc bought 301952 shares at $0.44 remaining shares owned 982783

Common Stock Pro Pharmaceuticals Inc Prwp Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 received as a dividend on class b convertible preferred stock owned by 10x fund, lp.
f2 10x fund, l.p. has direct beneficial ownership of all the securities owned by 10x fund, l.p. 10x capital management, llc, a florida limited liability company, is the general partner of 10x fund, l.p., a delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10x fund, l.p., such portion being equal to 10x capital management, llc's (a) 20% interest in the profits of 10x fund, l.p., (b) interest in any securities which are used to pay a 2% annual management fee to 10x capital management, llc, and (c) interest in one-half of the class b warrants acquired by 10x fund, l.p. in all closings other than the initial closing held on february 12, 2009, less one class b warrant which 10x capital management, llc has committed to reallocate to investors in all prior closings until each such investor has one (1) additional class b warrant for each dollar invested.
f3 10x capital management, llc disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.